This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Teladoc (TDOC) Unveils Solution to Ease Whole-Person Care
by Zacks Equity Research
Teladoc Health (TDOC) launches Chronic Care Complete for extending a comprehensive suite of chronic condition management services for serving the whole-person health needs of eligible members.
Is a Surprise Coming for Teladoc (TDOC) This Earnings Season?
by Zacks Equity Research
Teladoc (TDOC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What's in Store for Teladoc's (TDOC) Q4 Earnings?
by Zacks Equity Research
Teladoc Health's (TDOC) Q4 results are expected to gain from high sales and visits volume.
How Investors Can Grab Better Returns for Medical Using the Zacks ESP Screener
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Teladoc (TDOC) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Teladoc (TDOC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Community Health (CYH) Ties Up to Offer Enhanced Remote Care
by Zacks Equity Research
Community Health (CYH) teams up with Cadence highlighting its aim of utilizing innovative technology to extend enhanced remote care to patients.
Teladoc (TDOC) Stock Moves -0.79%: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $72.83, marking a -0.79% move from the previous day.
Teladoc (TDOC) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed the most recent trading day at $76.19, moving +0.9% from the previous trading session.
Teladoc (TDOC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $79.57, marking a +1.36% move from the previous day.
What's in Store for UnitedHealth Group's (UNH) Q4 Earnings?
by Zacks Equity Research
UnitedHealth's (UNH) Q4 results are likely to reflect a rise in earnings and revenues on the back of solid segmental contributions.
Teladoc (TDOC) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $82.18, marking a +0.51% move from the previous day.
Teladoc (TDOC) Ties Up to Offer Virtual Care for NLA Members
by Zacks Equity Research
Teladoc Health (TDOC) teams up with NLA in a bid to offer its comprehensive suite of virtual care services to benefit the latter's members.
Teladoc (TDOC) Falls 8.1% Despite Upbeat Revenue Guidance
by Zacks Equity Research
Teladoc Health (TDOC) expects revenues to rise to more than $4 billion in 2024.
Salesforce and Autohome have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Salesforce (CRM) as the Bull of the Day, and Autohome Inc. (ATHM) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Ford Motor Co. (F), eBay (EBAY), and Teladoc Health (TDOC).
Teladoc Health (TDOC) Q3 Loss Narrower Than Expected, Down Y/Y
by Zacks Equity Research
Teladoc Health's (TDOC) third-quarter results indicate improved revenues owing to higher access fees and visit fees, partly offset by elevated costs.
Teladoc (TDOC) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Teladoc (TDOC) delivered earnings and revenue surprises of 24.29% and 0.97%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Investors Book Profits Late; Q3 Reports for Ford, eBay, Teladoc
by Mark Vickery
Late-day selling in the regular session brought indexes to their lows for the day, but Ford is up in late trading on Q3 numbers.
4 Healthcare Stocks to Top Q3 Estimates Amid Coronavirus Woes
by Srijita Guha
Factors like an aging populace and demand for products and services are likely to reflect on the Q3 results of ACAD, MD, ACHC and VRTX.
Teladoc (TDOC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $140.53 in the latest trading session, marking a +0.04% move from the prior day.
What's in Store for Teladoc Health's (TDOC) Earnings in Q3?
by Zacks Equity Research
Teladoc Health (TDOC) is likely to report a strong revenue outperformance for the third quarter, driven by broad-based momentum across its business and a sharp acceleration in visit-volume growth.
Teladoc (TDOC) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Robust customer uptake and novel innovations are likely to have contributed to growth for Teladoc (TDOC).
Earnings Preview: Teladoc (TDOC) Q3 Earnings Expected to Decline
by Zacks Equity Research
Teladoc (TDOC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Teladoc (TDOC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $136.88, marking a +0.63% move from the previous day.
Syneos Health's (SYNH) New Pact Boosts Tech-Driven Solutions
by Zacks Equity Research
Syneos Health's (SYNH) recent acquisition boosts the company's ability to deliver strategic insights and technology-enabled solutions that address the customers' most complex data challenges.
Teladoc (TDOC) Broadens Accessibility of Primary Care Model
by Zacks Equity Research
Teladoc Health (TDOC) intends to offer enhanced primary care to its members through Primary360, whose reach has now extended to commercial health plans and employers.